← Back to headlines
Vertex names Jonathan Poole finance chief as Crinetics buy closes
Vertex Pharmaceuticals has named Jonathan Poole as its new finance chief, coinciding with the closing of Crinetics Pharmaceuticals' acquisition. The executive appointment aligns with broader corporate restructuring efforts.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
